Apyx Medical Corporation

Apyx Medical Corporation is an advanced energy technology company that designs, develops, manufactures, and sells medical devices for both the cosmetic and surgical markets globally. The company's mission is to elevate people's lives through innovative products, delivering transformative energy-based surgical tools aimed at improving patient outcomes, enhancing surgeon efficiency, and reducing healthcare costs. Headquartered in Clearwater, Florida, Apyx Medical was incorporated in 1982 and was formerly known as Bovie Medical Corporation, changing its name in January 2019.

The company's key product offerings are centered around its proprietary helium plasma and radiofrequency technology. These include Renuvion, marketed for the cosmetic surgery market, and J-Plasma, used in the hospital surgical market. Both technologies provide surgeons with the ability to deliver controlled heat to tissue for desired results. Apyx Medical also introduced the AYON Body Contouring System, an all-in-one, surgeon-designed platform that integrates fat removal, closed-loop contouring, electrosurgical capabilities, and Renuvion for tissue contraction. The company also engages in Original Equipment Manufacturing (OEM) agreements, leveraging its expertise in unique waveforms to develop generators and related accessories for other medical device manufacturers.

Under the leadership of President and CEO Charles D. Goodwin, Apyx Medical continues to advance its market position. In May 2024, Stavros Vizirgianakis was appointed Chairman of the Board. The company reported total revenue of $52.8 million for the full year 2025, with a significant portion driven by the commercial launch of the AYON Body Contouring System in September 2025. Apyx Medical's Renuvion technology received the 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener," marking consecutive recognition for its clinical impact. The company anticipates a 510(k) clearance for AYON power liposuction in mid-2026, further expanding its product capabilities.